ClinConnect ClinConnect Logo
Search / Trial NCT05624879

Accelerated Resolution Therapy for Early Maladaptive Grief

Launched by MAYO CLINIC · Nov 15, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Family Caregiver

ClinConnect Summary

This clinical trial is exploring a type of therapy called Accelerated Resolution Therapy (ART) to help older adult family caregivers who are experiencing intense grief before the loss of a loved one. The study aims to see how effective ART is for these caregivers and to learn more about what helps some people respond better to the therapy. If you are a primary caregiver for a family member who is expected to live less than a year and are feeling significant grief, you might be eligible to participate.

To join the trial, you need to be the main caregiver for someone who is seriously ill, and your feelings of grief must be strong enough that a screening test shows you need help. It's important that you are not currently experiencing thoughts of suicide or have serious mental health issues. Participants will receive ART, which is designed to help reduce grief and improve emotional well-being. Throughout the study, researchers will monitor how participants respond to the therapy and gather feedback on their experiences. This trial is currently looking for volunteers, and everyone is welcome to apply regardless of gender.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Primary caregiver of immediate family member who has a life expectancy of less than 12 months
  • Score of 30 or higher on the PG-12-R, indicating clinically significant pre-loss grief
  • Denial of suicidal ideation or intent, with no evidence of psychotic behavior.
  • Exclusion Criteria:
  • Since becoming a family caregiver (FCG), they have engaged in another trauma based psychotherapeutic regimen (EMDR, prolonged exposure therapy, trauma focused cognitive behavioral therapy) that could influence response to accelerated resolution therapy (ART).
  • Self-reported or clinically assessed major psychiatric disorder (e.g., bipolar disorder, schizophrenia).
  • Score of \> 2 on the adapted CAGE questionnaire indicating alcohol /drug dependence.
  • Cognitive impairment (SPMSQ \> 4 errors).

About Mayo Clinic

Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.

Locations

Rochester, Minnesota, United States

Jacksonville, Florida, United States

Phoenix, Arizona, United States

Jacksonville, Florida, United States

Clearwater, Florida, United States

Patients applied

0 patients applied

Trial Officials

Cindy Tofthagen, PhD

Principal Investigator

Mayo Clinic

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials